Contemporary Trends in Adjuvant and Neoadjuvant Treatment for Renal Cell Carcinoma
Journal Title: Üroonkoloji Bülteni - Year 2018, Vol 17, Issue 3
Abstract
Renal cell carcinoma is an increasingly significant cancer in which surgical resection is still the sole curative approach. There is a risk of recurrence in one-third of patients after surgery. Successful experiences with some solid organ cancers and effective treatment response to targeted agents in metastatic cases have suggested a similar adjuvant approach for renal cell carcinoma. Consequently, placebo-controlled adjuvant trials have been reported and the Food and Drug Administration approved sunutinib as an adjuvant treatment after nephrectomy in high-risk patients, with the risk of treatment-related side effects. Several clinical series have indicated that neoadjuvant application can provide significant downsizing of the cancer mass in complex cases and enable radical surgery. Similarly, neoadjuvant therapy could enable nephron-sparing surgery for certain patients. Both adjuvant and neoadjuvant approaches for renal cell carcinoma require further trials with larger patient numbers. This review presents contemporary experience on adjuvant and neoadjuvant treatment for renal cell carcinoma.
Authors and Affiliations
Kamil Çam
Keywords
Related Articles
- EP ID EP382524
- DOI 10.4274/uob.1030
- Views 108
- Downloads 0
Early and Late Complications of Urinary Diversions after Radical Cystectomy
One of the strongest predictive factors for the early and late postoperative complications and morbidity of radical cystectomy is the type of urinary diversion following cystectomy. In this paper, we reviewed English-lan...
The Relationship between Bladder Cancer and Epigenetic Alterations
Bladder cancer is one of the most common cancers of urinary system and approximately 70% of the cases are low grade and non-muscle invasive. Because of the histological indicator inadequacy of heterogeneous tumors like b...
Rare Benign and Uncertain Malignant Potential Tumors of Bladder: Review of the Literature
The most common primary bladder cancer are transitional cell (urothelial) carcinomas. However, there are several uncommon but significant bladder lesions that must be differentiated from urothelial carcinomas. These blad...
Association Between Postoperative 3rd Month Renal Function After Radical Cystectomy and Preoperative Factors, Oncologic Outcomes, and Complications
Objective: We aimed to investigate the influence of preoperative factors on postoperative renal function and the association between renal function and oncologic outcomes and complications after radical cystectomy (RC)....
Additional Surgical Procedures During Postchemotherapy Retroperitoneal Lymph Node Dissection in Patients with Nonseminomatous Testicular Tumor
Objective: Retroperitoneal lymph node dissection (RLND) is frequently performed in non-seminomatous testicular tumor (TT) patients, especially in cases who have radiological residual mass despite normal tumor markers aft...